Table 1 ATI patients in the ACSL4high group showed a decline of kidney function.
From: XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury
Variables | All (n = 45) | ACSL4low (n = 30) | ACSL4high (n = 15) | P |
---|---|---|---|---|
Gender | ||||
Male | 25 | 15 (50%) | 10 (66.7%) | |
Female | 20 | 15 (50%) | 5 (33.3%) | 0.2888 |
Age (years) | 46.0 (27.5, 54.5) | 50.0 (34.0, 57.25) | 33.0 (26.0, 52.0) | 0.0495 |
Hematuria | ||||
<3+ (%) | 21 | 19 (70.4%) | 12 (84.6%) | |
≥3+ (%) | 14 | 11 (29.6%) | 3 (15.4%) | 0.2549 |
Proteinuria | ||||
<3+ (%) | 25 | 18 (60.0%) | 7 (46.7%) | |
≥3+ (%) | 20 | 12 (40.0%) | 8 (53.3%) | 0.3961 |
Hb(g/L) | 122.0 (107.0,135.0) | 123.0 (114.8,136.8) | 114.5 (98.93,130.1) | 0.2533 |
Blood urea nitrogen (mmol/L) | 7.4 (6.1, 12.8) | 7.2 (5.7, 8.1) | 13.8 (7.4, 16.3) | 0.0151 |
Serum creatinine (μmol/L) | 128.0 (100.5, 237.5) | 121.5 (94.8, 136.0) | 244.0 (127.0, 340.0) | 0.0026 |
Serum uric acid (μmol/L) | 383.1 (324.8, 423.5) | 377.2 (324.0, 416.2) | 415 (337.0, 417.0) | 0.1980 |
eGFR (mL/min/1.73 m2) | 51.5 (25.9, 58.8) | 56.2 (40.6, 69.4) | 26.7 (18.9, 55.0) | 0.0084 |
Serum albumin (g/L) | 37.2 (25.7, 42.7) | 37.7 (30.2, 44.7) | 34.4 (18.1, 40.8) | 0.1288 |
Serum total cholesterol | 4.7 (4.0, 7.5) | 4.6 (3.8, 5.9) | 5.0 (4.0, 9.1) | 0.2485 |